Sensitization associated with stressors and cytokine treatments

被引:74
作者
Anisman, H [1 ]
Merali, Z
Hayley, S
机构
[1] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada
[2] Univ Ottawa, Royal Ottawa Hosp, Mental Hlth Res Inst, Ottawa, ON, Canada
[3] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada
关键词
cytokine; interleukin; tumor necrosis factor; neuroendocrine; sensitization; corticosterone; CRH; norepinephrine; serotonin; depression;
D O I
10.1016/S0889-1591(02)00100-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Like stressors, interleukin-1beta and tumor necrosis factor-alpha (TNF-alpha) increase hypothalamic-pituitary-adrenal (HPA) activity and monoamine turnover at hypothalamic and extrahypothalamic sites. These effects can be re-elicited more readily upon reintroduction of these challenges (sensitization), depending on their time of re-exposure and the particular system being assessed. Following TNF-alpha administration, the co-expression of corticotropin releasing hormone (CRH) and arginine vasopressin increased within the median eminence, peaking 7-14 days after treatment, and was associated with an early corticosterone sensitization. However, the re-elicitation of sickness symptoms and corticosterone release was most pronounced at lengthy re-exposure intervals (28 days), possibly reflecting histamine release from mast cells. In addition, the cytokine engendered the sensitization of norepinephrine and serotonin utilization, and CRH immunoreactivity at mesocorticolimbic sites, but these effects were most prominent at brief re-exposure intervals (1-7 days). Cytokines may independently prime multiple regulatory systems, and by virtue of the neurochemical changes imparted, have both immediate and proactive influences on the evolution of psychopathology. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:86 / 93
页数:8
相关论文
共 23 条
[1]   Cytokines, stress, and depressive illness [J].
Anisman, H ;
Merali, Z .
BRAIN BEHAVIOR AND IMMUNITY, 2002, 16 (05) :513-524
[2]  
Anisman H, 1993, Rev Neurosci, V4, P147
[3]  
Anisman H, 1999, ADV EXP MED BIOL, V461, P199
[4]  
BEALER SL, 1993, J PHARMACOL EXP THER, V264, P734
[5]   The physiology of brain histamine [J].
Brown, RE ;
Stevens, DR ;
Haas, HL .
PROGRESS IN NEUROBIOLOGY, 2001, 63 (06) :637-672
[6]   The action of tumor necrosis factor-α on rat mast cells [J].
Brzezinska-Blaszczyk, E ;
Forczmanski, M ;
Pietrzak, A .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2000, 20 (04) :377-382
[7]   The amygdala: vigilance and emotion [J].
Davis, M ;
Whalen, PJ .
MOLECULAR PSYCHIATRY, 2001, 6 (01) :13-34
[8]   Sensitization to the neuroendocrine, central monoamine and behavioural effects of murine tumor necrosis factor-α:: peripheral and central mechanisms [J].
Hayley, S ;
Wall, P ;
Anisman, H .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2002, 15 (06) :1061-1076
[9]   Murine tumor necrosis factor-α sensitizes plasma corticosterone activity and the manifestation of shock:: modulation by histamine [J].
Hayley, S ;
Kelly, O ;
Anisman, H .
JOURNAL OF NEUROIMMUNOLOGY, 2002, 131 (1-2) :60-69
[10]  
Hayley S, 1999, J NEUROSCI, V19, P5654